duloxetine
Selected indexed studies
- Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis. (BMJ Support Palliat Care, 2023) [PMID:36194493]
- Duloxetine. (J Psychiatr Pract, 2004) [PMID:15583519]
- Is duloxetine an alternative in the treatment of osteoarthritis? (Medwave, 2017) [PMID:29053665]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis. (2023) pubmed
- Duloxetine. (2004) pubmed
- Is duloxetine an alternative in the treatment of osteoarthritis? (2017) pubmed
- Duloxetine in Painful Diabetic Neuropathy: A Systematic Review. (2016) pubmed
- Duloxetine to prevent neuropathy in breast cancer patients under paclitaxel chemotherapy (a double-blind randomized trial). (2024) pubmed
- Comparative analysis of the therapeutic effects of pregabalin, gabapentin, and duloxetine in diabetic peripheral neuropathy: A retrospective study. (2025) pubmed
- Duloxetine-Associated Photodistributed Erythema Multiforme. (2022) pubmed
- Perioperative Duloxetine in Total Joint Arthroplasty: An Umbrella Review. (2025) pubmed
- Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis. (2019) pubmed
- Duloxetine hydrochloride. (2004) pubmed